In a report released today, Matt Miksic from Barclays maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price ...

In a report released on January 17, Shagun Singh Chadha from RBC Capital maintained a Buy rating on Abbott Laboratories (ABT – Research Report), with a price target of $135.00. The company’s ...

The company reported revenue of $10.97 billion and earnings of $1.34 on a per-share and adjusted basis, compared to the ...

ABT offers single-use columns suitable for FPLC and ÄKTA design™ chromatography systems. These columns meet the demands in both academia and biopharma. Easy to use just fill different sized ...

Welcome to Abbott's fourth quarter 2024 earnings conference call. [Operator instructions] This call is being recorded by ...

Abbott (ABT) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

They start by talking about an imminent webinar, hosted by CC and featuring elite telecoms hacks, that aims to set the scene for the Mobile World Congress trade show, leading to plenty of tangents ...

Telecom companies have a good track record with automating services. AI offers an opening for automating customer service, as well as new opportunities for capex optimisation. In addition to cost ...

Adds response from Consolidated Communications. Chinese hackers breached more U.S. telecoms than previously thought, The Wall Street Journal reported late Saturday, citing people familiar with the ...

Copyright © 2025 MarketWatch, Inc. All rights reserved.